NDC 69367-416 – Butalbital, Aspirin, And Caffeine

Butalbital 50 mg/1; Aspirin 325 mg/1; Caffeine 40 mg/1 · Capsule · Oral

Human Prescription Drug DEA schedule CIII

Product NDC69367-416

Product details

Brand name
Butalbital, Aspirin, And Caffeine
Generic name
Butalbital, Aspirin, And Caffeine
Labeler
Westminster Pharmaceuticals, LLC
Dosage form
Capsule
Route
Oral
Marketing category
ANDA · ANDA078149
Marketed since
October 24, 2025
Listing expires
December 31, 2027
Pharmacologic class
Barbiturate; Central Nervous System Stimulant; Methylxanthine; Nonsteroidal Anti-inflammatory Drug; Platelet Aggregation Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Butalbital, Aspirin, And Caffeine →

Package NDC codes (1)

Package NDCDescriptionSince
69367-416-01100 CAPSULE in 1 BOTTLE (69367-416-01)Oct 24, 2025

Other Butalbital, Aspirin, And Caffeine products